Clostridium difficile infection in a long-term care facility: Hospital-associated illness compared with long-term care-associated illness

Infection Control and Hospital Epidemiology

Volumn 32, Issue 7, 2011, Pages 656-660

  Kim, Jong Hun ^a   Toy, Diana ^b   Muder, Robert R ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM TOXIN; ENDOTOXIN;

ACUTE DIARRHEA; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HOSPITAL INFECTION; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RELAPSE; RISK; UNITED STATES;

AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; CROSS INFECTION; FEMALE; HOSPITALS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SKILLED NURSING FACILITIES;

EID: 79958752799     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/660767     Document Type: Article

References (19)

1. Gerding DN, Johnson S, Peterson LR, et al. Clostridium difficile diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16: 459-477.
2. Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981;143(1):42-50.
3. Pépin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173(9):1037-1042.
4. Makris AT, Gelone S. Clostridium difficile in the long-term care setting. J Am Med Dir Assoc 2007;8(5):290-299.
5. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28:140-145.
6. Mylotte JM. Surveillance for Clostridium difficile-associated diarrhea in long-term care facilities: what you get is not what you see. Infect Control Hosp Epidemiol 2008;29(8):760-763.
7. Cohen SH, Gerding DN, Johnson S, et al; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431-455.
8. Chang HT, Krezolek D, Johnson S, Parada JP, Evans CT, Gerding DN. Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital. Infect Control Hosp Epidemiol 2007;28(8):926-931.
9. Laffan AM, Bellantoni MF, Greenough WB III, Zenilman JM. Burden of Clostridium difficile-associated diarrhea in a longterm care facility. J Am Geriatr Soc 2006;54(7):1068-1073.
10. Bender BS, Bennett R, Laughon BE, et al. Is Clostridium difficile endemic in chronic-care facilities? Lancet 1986;2(8497):11-13.
11. Ellingson K, Muder RR, Jain R, et al. Sustained reduction in the clinical incidence of methicillin-resistant Staphylococcus aureus colonization or infection associated with a multifaceted infection control intervention. Infect Control Hosp Epidemiol 2011;32(1):1-8.
12. Muder RR, Cunningham C, McCray E, et al. Implementation of an industrial systems-engineering approach to reduce the incidence of methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol 2008;29:702-708.
13. Muder RR, Cheryl SL, Cunningham C, Morris LA, Jain R. Hospital- associated infection due to MRSA and other multiply resistant organisms after a hospital-wide control program: 4 year follow-up. In: Programs and abstracts of the Fifth Decennial International Conference on Healthcare-Associated Infections. Atlanta: SHEA, 2010. Abstract 551.
14. Aseeri M, Schroeder T, Kramer J, Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 2008;103(9):2308-2313.
15. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990;162(3):678-684.
16. Buchner AM, Sonnenberg A. Epidemiology of Clostridium difficile infection in a large population of hospitalized US military veterans. Dig Dis Sci 2002;47(1):201-207.
17. Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000;38(6): 2386-2388.
18. Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001;357(9251):189-193.
19. Kvach EJ, Ferguson D, Riska PF, Landry ML. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol 2010;48(1):109-114